Culturally Focused Mental Health Startup Bliss Raises $270.000
  • News
  • Europe

Culturally Focused Mental Health Startup Bliss Raises $270.000

The Finnish-Albanian startup is building AI that understands the cultural layer of mental health.

3/11/2026
Yassin El Hardouz
Back to News

Bliss, a mental health startup with roots in Albania and its headquarters in Finland, has successfully raised $270,000 in an angel funding round. The investment was led by Keiretsu Forum, Finest Love VC, and Plug and Play to advance its culturally intelligent AI therapy platform. This new capital will enable the company to better address the mental health needs of diverse global populations and diaspora communities.


Addressing a Global Gap in Mental Healthcare

A significant gap exists in the digital mental healthcare market, which often overlooks crucial cultural nuances in therapy. With over 800 million people worldwide living outside their country of origin, most platforms are still designed for monolingual and culturally uniform markets. Bliss aims to solve this by recognizing that effective therapy requires a deep contextual understanding beyond simple language translation.

The platform currently connects users with a network of over 50 licensed therapists located in more than ten countries. It employs sophisticated AI-powered systems to facilitate precise cultural and linguistic matching, ensuring a deeper level of understanding between a client and therapist. This method provides care that is genuinely sensitive to an individual's unique background and personal experiences.

A New Approach to AI in Therapy

Differentiating itself from the growing number of generic AI chatbots, Bliss is developing innovative therapist-trained digital companions. These supervised AI systems are designed to mirror a human therapist’s specific style, tone, and therapeutic approach. The primary goal is to extend professional support between sessions rather than attempting to replace the essential human connection in therapy.

Founder and CEO Jona Doda emphasized the company's unique focus on integrating cultural context into its technology. "We’re not building another chatbot," she stated, highlighting that most systems fail at the cultural layer of mental health. Bliss is instead building AI infrastructure that amplifies the effectiveness and reach of human-led care.

Investor Confidence and Early Momentum

The investment round is backed by prominent global innovation leaders, signaling strong confidence in the startup's forward-thinking vision. Keiretsu Forum, Finest Love VC, and Plug and Play bring extensive networks and expertise from North America, the Nordics, and Silicon Valley. This diverse support reflects Bliss's own cross-border operational strategy between its offices in Helsinki and Tirana.

Dr. Ravik Mima, CEO of Keiretsu Forum SEE, praised the company's responsible model for the future of AI in mental health. He highlighted that Bliss is building a clinically grounded and culturally aware system with strong human guardrails. This approach provides access to world-class therapists when it matters most, addressing a critical need in the market.

Strategic Expansion and Future Plans

With the new capital, Bliss plans to launch the first version of its therapist-trained AI companions. The company will also expand into additional diaspora markets, including the United States, to serve a wider international audience. A key focus will be scaling B2B partnerships with multinational employers seeking culturally competent mental health solutions for their workforce.

The company has already demonstrated promising early traction with an active user base across ten countries. It has successfully onboarded more than 50 licensed therapists and secured B2B clients such as Raiffeisen Bank and We Love Mondays. This progress provides a solid foundation for its planned expansion and further technology development.


As the digital mental health market becomes increasingly saturated, Bliss is carving out a distinct and necessary niche. By prioritizing cultural intelligence and integrating AI as a tool to support clinicians, the company is championing a more nuanced and effective approach. This focus on augmenting human expertise may prove to be the defining factor for its long-term success and impact.